OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
iProX
(1)
Publication Date
2022
(1)
Release Date
2020
(3)
2021
(2)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Nascent DNA-associated proteome of POLE1-depleted cells
iPOND experiment was performed on control and dox-aux treated U2OS cells in which POLE1 was endogenously tagged with an auxin-inducible degron
ORGANISM(S):
Homo Sapiens
2022-05-07
|
PXD033757
|
Cite
Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer.
Not available
S-EPMC8140803
|
biostudies-literature
Cite
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.
Not available
S-EPMC7430178
|
biostudies-literature
Cite
SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation
Not available
S-EPMC7208240
|
biostudies-literature
Cite
Efficacy of Selpercatinib in
RET
Fusion-Positive Non-Small-Cell Lung Cancer.
Not available
S-EPMC7506467
|
biostudies-literature
Cite
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.
Not available
S-EPMC8009613
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets